Optimising schistosomiasis treatments: the Praziquantel in Preschool-aged Children (PIP) trial

Optimising schistosomiasis treatments: the Praziquantel in Preschool-aged Children (PIP) trial

In this GSA & ISNTD presentation, we welcome Dr Andrew Edielu (London School of Hygiene & Tropical Medicine, LSHTM, UK; MRC Uganda Virus Research Institute, Uganda; LSHTM Uganda Research Unit) sharing methods and results from the Praziquantel in Preschool-aged Children trial, with important implications for optimizing the treatment of schistosomiasis in this age group. Recorded on November 26, 2025 as part of the webinar: Optimising schistosomiasis treatment for preschool-aged children: A pragmatic approach from research to practice, with - ​​​​​Prof Amaya Bustinduy (London School of Hygiene & Tropical Medicine (LSHTM), UK) - Dr Andrew Edielu (London School of Hygiene & Tropical Medicine (LSHTM), UK; MRC Uganda Virus Research Institute (MRC/UVRI), Uganda; LSHTM Uganda Research Unit) - Dr Narcis B Kabatereine (Ministry of Health, Uganda) - With remarks from Dr Amadou Garba (WHO)​​ Recording of the full session: https://youtu.be/IiQxthp9azM Register for the #ISNTDConnect series: https://www.isntd.org/isntd-connect